NCT07036393

Brief Summary

This study was done to:

  • Determine the therapeutic efficacy of acupuncture as physical therapy approach in minimizing pain post upper abdominal surgeries.
  • Determine the therapeutic efficacy of transcutaneous electrical nerve stimulation in minimizing pain post upper abdominal surgeries.
  • Compare the efficacy and safety of Transcutaneous electrical nerve stimulation versus acupuncture in minimizing pain post upper abdominal surgeries.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 14, 2025

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 25, 2025

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
Last Updated

June 25, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

June 14, 2025

Last Update Submit

June 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • assessment of change of postoperative quality of recovery

    The Postoperative Quality of Recovery Scale is a verbal scale designed to assess the quality of recovery in six domains: physiology, nociceptive, emotional, activities of daily living, cognitive, and overall patient perspective. It measures systolic blood pressure, heart rate, temperature, respiratory rate, oxygen saturation, and airway control, aiming to assess physiologic safety and home readiness for day care surgery. It also assesses pain and nausea using a 1-5% Likert rating scale. Emotional domain measures feelings of anxiety and depression. Activities of daily living assess physical return to normality through daily activities, with scores ranging from 3 to 1. Cognitive domain measures orientation, verbal memory, executive functioning, attention, and concentration. Performance variability tolerance factors are applied to ensure participants are not included in subsequent analysis if baseline scores are equal to or less than the tolerance factor.

    At baseline and 4 weeks

Secondary Outcomes (1)

  • assessment of change of pressure pain threshold

    At baseline and 4 weeks

Study Arms (2)

Acupuncture

EXPERIMENTAL

This group includes 20 patients who will receive Acupuncture 4 weeks (3times/week) and medical treatment

Other: AcupunctureOther: drugs

Transcutaneous electrical nerve stimulation

ACTIVE COMPARATOR

This group includes 20 patients who will receive Transcutaneous electrical nerve stimulation 4 weeks (3times/week) and medical treatment

Other: Transcutaneous electrical nerve stimulationOther: drugs

Interventions

Cholecystectomy involves a procedure where patients' spines are kept in position and skin around the acupoints is disinfected with 75% alcohol. Acupuncture treatment is given when patients return to units within 2 hours after surgery. The needles are inserted using disposable sterile needles and manipulated to induce a sense of "De qi" (soreness, numbness, distension, or heaviness). Gastrectomy involves daily acupuncture sessions for 5 consecutive days, starting on postoperative day 1. The needles are inserted perpendicular to the acupoints in the extremities to a depth of approximately 20 mm from the skin surface.

Acupuncture

Patients will receive a transcutaneous electrical nerve stimulation unit (ENNRAF) for up to 48 hours post-surgery, with instructions to self-titrate intensity for pain relief. Postoperative stimulation will be 20-40 milliampere and pulse width 5

Transcutaneous electrical nerve stimulation
drugsOTHER

analgesics and nonsteroidal anti-inflammatory drugs

AcupunctureTranscutaneous electrical nerve stimulation

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who will have pain after upper abdominal surgery.
  • Adult patients will be between 20 and 45 years of age.
  • Both sexes will be included.
  • Patients have no contraindications for acupuncture or transcutaneous electrical nerve stimulation.
  • Patients with good compliance and fit for treatment.
  • This study will be applied on upper abdominal surgeries \[laparoscopic cholecystectomy, Gastrectomy\].
  • Physical therapy will be used for up to 48 hours after surgery or until the time of discharge.

You may not qualify if:

  • Patients with other causes of pain other than that after upper abdominal surgery.
  • Patients who will have any contraindication for both therapies used.
  • Patients with cardiovascular disease, liver, or renal disease.
  • Patients with malignant tumors.
  • Patients with metal or electronic implants.
  • Patients with autoimmune disease.
  • Pregnancy, postpartum period, breastfeeding.
  • Patients with recent injury in the treatment area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura international hospital

Al Mansurah, Egypt

RECRUITING

MeSH Terms

Conditions

Pain

Interventions

Acupuncture TherapyTranscutaneous Electric Nerve StimulationPharmaceutical Preparations

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Central Study Contacts

Samar Saad Nazim Mohamed, physical therapist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

June 14, 2025

First Posted

June 25, 2025

Study Start

April 15, 2025

Primary Completion

June 15, 2025

Study Completion

July 15, 2025

Last Updated

June 25, 2025

Record last verified: 2025-06

Locations